News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Conference News ACC 2022 POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery Todd Neale April 02, 2022
News Daily News Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19 Todd Neale March 25, 2022
News Daily News More Evidence Links Breast Arterial Calcification and CVD Risk L.A. McKeown March 15, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Features When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles Todd Neale September 28, 2021
News Daily News Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b Shelley Wood June 22, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Daily News Thrombotic Events Frequent Among COVID-19 Patients in ICUs Michael O'Riordan October 27, 2020
News Conference News ESC 2020 Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism Caitlin E. Cox September 04, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response L.A. McKeown June 25, 2020
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020